EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Biomarkers of immediate drug hypersensitivity

Cristobalina Mayorga iD, Adriana Ariza iD, Rosa Muñoz-Cano iD, Vito Sabato iD, Inmaculada Doña iD, Maria J Torres iD

Allergy · 2024

DOI: 10.1111/all.15933 ↗

At a glance

Übersichtsarbeit in Allergy, 2024. Written by Cristobalina Mayorga and 5 co-authors. Institution: Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina - IBIMA Plataforma BIONAND, Málaga, Spain. Major MEDLINE topics: Drug Hypersensitivity, Hypersensitivity, Immediate, Hypersensitivity. Cited 25 times so far (Crossref); 130 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Institute of Health 'Carlos III' (ISCIII) of the Ministry of Economy and Competitiveness (MINECO) (co-funded by European Regional Development Fund), Andalusian Regional Ministry of Health, ISCIII thorough AES 2019 within the ERANET-EuroNanoMed-III framework (DrNanoDall project).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Immediate drug hypersensitivity reactions (IDHRs) are a burden for patients and the health systems. This problem increases when taking into account that only a small proportion of patients initially labelled as allergic are finally confirmed after an allergological workup. The diverse nature of drugs involved will imply different interactions with the immunological system. Therefore, IDHRs can be produced by a wide array of mechanisms mediated by the drug interaction with specific antibodies or directly on effector target cells. These heterogeneous mechanisms imply an enhanced complexity for an accurate diagnosis and the identification of the phenotype and endotype at early stages of the reaction is of vital importance. Currently, several endophenotypic categories (type I IgE/non‐IgE, cytokine release, Mast‐related G‐protein coupled receptor X2 (MRGPRX2) or Cyclooxygenase‐1 (COX‐1) inhibition and their associated biomarkers have been proposed. A precise knowledge of endotypes will permit to discriminate patients within the same phenotype, which is crucial in order to personalise diagnosis, future treatment and prevention to improve the patient's quality of life.

Subjects

MeSH terms (MEDLINE)

Drug HypersensitivityHypersensitivity, ImmediateHypersensitivityHumansQuality of LifeBiomarkersReceptors, G-Protein-CoupledMast CellsCell DegranulationNerve Tissue ProteinsReceptors, Neuropeptide

Author keywords

biomarkerdrughypersensitivityimmediate

Substances

BiomarkersReceptors, G-Protein-CoupledMRGPRX2 protein, humanNerve Tissue ProteinsReceptors, Neuropeptide

Authors and institutions

  • Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina - IBIMA Plataforma BIONAND, Málaga, Spain.
  • Allergy Unit, Hospital Regional Universitario de Málaga-HRUM, Málaga, Spain.
  • Allergy Department, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer - IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Department of Immunology, Allergology, Rheumatology, Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Medicine Department, Universidad de Málaga-UMA, Málaga, Spain.

ORCID profiles: Cristobalina Mayorga, Adriana Ariza, Rosa Muñoz-Cano, Vito Sabato, Inmaculada Doña, Maria J Torres

Funding

  • Institute of Health 'Carlos III' (ISCIII) of the Ministry of Economy and Competitiveness (MINECO) (co-funded by European Regional Development Fund)
  • Andalusian Regional Ministry of Health
  • ISCIII thorough AES 2019 within the ERANET-EuroNanoMed-III framework (DrNanoDall project)
  • Flemish Research Council

Cite

APA

Mayorga, C., Ariza, A., Muñoz-Cano, R., Sabato, V., Doña, I., & Torres, M. J. (2024). Biomarkers of immediate drug hypersensitivity. Allergy. https://doi.org/10.1111/all.15933

Vancouver

Mayorga C, Ariza A, Muñoz-Cano R, Sabato V, Doña I, Torres MJ. Biomarkers of immediate drug hypersensitivity. Allergy. 2024. doi:10.1111/all.15933

BibTeX
@article{Mayorga2024,
  author = {Mayorga, Cristobalina and Ariza, Adriana and Muñoz-Cano, Rosa and Sabato, Vito and Doña, Inmaculada and Torres, Maria J},
  title = {Biomarkers of immediate drug hypersensitivity},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.15933}
}
Start for free →